Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
GLP-1 RAs are well-documented for their ability to lower glucose levels, induce modest weight loss, and reduce blood pressure
Evidence from clinical trials and the clinic suggests GLP-1-associated side effects are not uncommon
It is not approved for human consumption outside of controlled, ethically approved clinical trials and laboratory environments
2023 Dec 5
[175] In the STEP-HFpEF trial including people with obesity and heart failure with preserved ejection fraction, weight loss was associated with improvements in heart failure symptoms and functional capacity
US$ 21.84
US$ 28.42
US$ 25.57
